Bank of America’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.5M | Buy |
111,736
+28,078
| +34% | +$1.05M | ﹤0.01% | 3551 |
|
|
2025
Q4 | $2.91M | Sell |
83,658
-27,622
| -25% | -$2.17M | ﹤0.01% | 3779 |
|
|
2025
Q3 | $9.25M | Sell |
111,280
-26,271
| -19% | -$1.9M | ﹤0.01% | 3391 |
|
|
2025
Q2 | $10.1M | Sell |
137,551
-2,419
| -2% | -$175K | ﹤0.01% | 3214 |
|
|
2025
Q1 | $16M | Buy |
139,970
+41,316
| +42% | +$2.51M | ﹤0.01% | 2691 |
|
|
2024
Q4 | $4.97M | Sell |
98,654
-62,711
| -39% | -$3.29M | ﹤0.01% | 3594 |
|
|
2024
Q3 | $7.47M | Sell |
161,365
-13,489
| -8% | -$479K | ﹤0.01% | 3364 |
|
|
2024
Q2 | $5.68M | Sell |
174,854
-498,500
| -74% | -$13.7M | ﹤0.01% | 3503 |
|
|
2024
Q1 | $17M | Buy |
673,354
+385,951
| +134% | +$9.12M | ﹤0.01% | 2453 |
|
|
2023
Q4 | $9.33M | Buy |
287,403
+100,192
| +54% | +$2.75M | ﹤0.01% | 2964 |
|
|
2023
Q3 | $5.1M | Buy |
187,211
+88,767
| +90% | +$2.57M | ﹤0.01% | 3379 |
|
|
2023
Q2 | $2.19M | Sell |
98,444
-13,153
| -12% | -$303K | ﹤0.01% | 4150 |
|
|
2023
Q1 | $2.42M | Buy |
111,597
+12,738
| +13% | +$279K | ﹤0.01% | 4188 |
|
|
2022
Q4 | $2.01M | Buy |
98,859
+15,641
| +19% | +$392K | ﹤0.01% | 4249 |
|
|
2022
Q3 | $2.13M | Sell |
83,218
-13,250
| -14% | -$355K | ﹤0.01% | 4207 |
|
|
2022
Q2 | $2.29M | Sell |
96,468
-7,603
| -7% | -$166K | ﹤0.01% | 4184 |
|
|
2022
Q1 | $2.34M | Sell |
104,071
-64,473
| -38% | -$1.37M | ﹤0.01% | 4435 |
|
|
2021
Q4 | $3.34M | Sell |
168,544
-43,734
| -21% | -$887K | ﹤0.01% | 4046 |
|
|
2021
Q3 | $4.18M | Buy |
212,278
+45,219
| +27% | +$946K | ﹤0.01% | 3732 |
|
|
2021
Q2 | $3.67M | Sell |
167,059
-51,071
| -23% | -$1.14M | ﹤0.01% | 3802 |
|
|
2021
Q1 | $5.19M | Buy |
218,130
+108,292
| +99% | +$2.89M | ﹤0.01% | 3358 |
|
|
2020
Q4 | $2.87M | Sell |
109,838
-40,988
| -27% | -$864K | ﹤0.01% | 3630 |
|
|
2020
Q3 | $2.63M | Buy |
150,826
+71,793
| +91% | +$1.14M | ﹤0.01% | 3464 |
|
|
2020
Q2 | $1.33M | Sell |
79,033
-8,228
| -9% | -$116K | ﹤0.01% | 3922 |
|
|
2020
Q1 | $1.04M | Buy |
87,261
+29,129
| +50% | +$360K | ﹤0.01% | 3985 |
|
|
2019
Q4 | $703K | Sell |
58,132
-79,403
| -58% | -$1.11M | ﹤0.01% | 4768 |
|
|
2019
Q3 | $1.94M | Buy |
137,535
+57,004
| +71% | +$700K | ﹤0.01% | 4080 |
|
|
2019
Q2 | $898K | Sell |
80,531
-41,930
| -34% | -$467K | ﹤0.01% | 4636 |
|
|
2019
Q1 | $1.44M | Sell |
122,461
-41,463
| -25% | -$515K | ﹤0.01% | 4248 |
|
|
2018
Q4 | $2.19M | Buy |
163,924
+106,823
| +187% | +$1.41M | ﹤0.01% | 3764 |
|
|
2018
Q3 | $801K | Sell |
57,101
-24,915
| -30% | -$348K | ﹤0.01% | 4630 |
|
|
2018
Q2 | $1.29M | Sell |
82,016
-517,841
| -86% | -$9.01M | ﹤0.01% | 4307 |
|
|
2018
Q1 | $9.87M | Buy |
599,857
+463,494
| +340% | +$8.59M | ﹤0.01% | 2421 |
|
|
2017
Q4 | $2.46M | Buy |
136,363
+69,237
| +103% | +$1.25M | ﹤0.01% | 3776 |
|
|
2017
Q3 | $1.3M | Buy |
67,126
+12,175
| +22% | +$182K | ﹤0.01% | 4327 |
|
|
2017
Q2 | $649K | Sell |
54,951
-3,452
| -6% | -$37.5K | ﹤0.01% | 4731 |
|
|
2017
Q1 | $640K | Buy |
58,403
+21,368
| +58% | +$188K | ﹤0.01% | 4720 |
|
|
2016
Q4 | $269K | Buy |
37,035
+9,063
| +32% | +$71K | ﹤0.01% | 5181 |
|
|
2016
Q3 | $182K | Sell |
27,972
-2,720
| -9% | -$15.8K | ﹤0.01% | 5163 |
|
|
2016
Q2 | $168K | Buy |
30,692
+24,343
| +383% | +$127K | ﹤0.01% | 5294 |
|
|
2016
Q1 | $30K | Buy |
6,349
+911
| +17% | +$3.55K | ﹤0.01% | 5971 |
|
|
2015
Q4 | $27K | Buy |
5,438
+3,287
| +153% | +$14.8K | ﹤0.01% | 6310 |
|
|
2015
Q3 | $8K | Sell |
2,151
-8,176
| -79% | -$41.5K | ﹤0.01% | 6628 |
|
|
2015
Q2 | $62K | Buy |
10,327
+10,195
| +7,723% | +$62.5K | ﹤0.01% | 5831 |
|
|
2015
Q1 | $1K | Buy |
+132
| New | +$478 | ﹤0.01% | 6788 |
|
|
2014
Q3 | – | Sell |
-9,824
| Closed | -$28K | – | 8014 |
|
|
2014
Q2 | $28K | Buy |
9,824
+8,704
| +777% | +$25.7K | ﹤0.01% | 7005 |
|
|
2014
Q1 | $5K | Buy |
1,120
+1,112
| +13,900% | +$3.89K | ﹤0.01% | 7351 |
|
|
2013
Q4 | $0 | Sell |
8
-572
| -99% | -$1.16K | ﹤0.01% | 7907 |
|
|
2013
Q3 | $1K | Sell |
580
-2,387
| -80% | -$4.21K | ﹤0.01% | 7726 |
|
|
2013
Q2 | $5K | Buy |
+2,967
| New | +$5.33K | ﹤0.01% | 7355 |
|
Other funds holding CORT
ISL
VPM
VCM
PA
Bank of America's CORT Position: Q1 2026 in Review
Bank of America increased its Corcept Therapeutics (CORT) stake by 34% in Q1 2026, buying an estimated $1.05M and bringing the position to 111,736 shares worth $4.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3551.
Bank of America first reported a position in CORT in Q2 2013 and has held it in 50 quarters since. The position peaked at $17M in Q1 2024. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.
- Bank of America held 111,736 shares of Corcept Therapeutics worth $4.5M as of Q1 2026.
- Bank of America bought 28,078 Corcept Therapeutics shares in Q1 2026, an estimated $1.05M.
- Corcept Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3551 holding.
- Bank of America first reported a position in Corcept Therapeutics in Q2 2013 and has held it in 50 quarters since.
- Bank of America's Corcept Therapeutics position peaked at $17M in Q1 2024.
- 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.